1-6 of 6
Dario A.A. Vignali
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Pathways and Mechanisms of LAG3 in Cancer Therapy

Lawrence P. Andrews, Anthony R. Cillo, Lilit Karapetyan, John M. Kirkwood, Creg J. Workman, Dario A.A. Vignali
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (23): 5030–5039.
https://doi.org/10.1158/1078-0432.CCR-21-2390
Published: 01 December 2022
View article titled, Molecular Pathways and Mechanisms of LAG3 in Cancer Therapy
Open the PDF for Molecular Pathways and Mechanisms of LAG3 in Cancer Therapy in another window
Journal Articles

Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks

Anthony R. Cillo, Elina Mukherjee, Nathanael G. Bailey, Sayali Onkar, Jessica Daley, Claudia Salgado, Xiang Li, Dongyan Liu, Sarangarajan Ranganathan, Melissa Burgess, John Sembrat, Kurt Weiss, Rebecca Watters, Tullia C. Bruno, Dario A.A. Vignali, Kelly M. Bailey
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (22): 4968–4982.
https://doi.org/10.1158/1078-0432.CCR-22-1471
Published: 14 November 2022
View article titled, Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks
Open the PDF for Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer

Robert L. Ferris, Jessica Moskovitz, Sheryl Kunning, Ayana T. Ruffin, Carly Reeder, James Ohr, William E. Gooding, Seungwon Kim, Brian J. Karlovits, Dario A.A. Vignali, Umamaheswar Duvvuri, Jonas T. Johnson, Daniel Petro, Dwight E. Heron, David A. Clump, Tullia C. Bruno, Julie E. Bauman
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1335–1344.
https://doi.org/10.1158/1078-0432.CCR-21-0426
Published: 01 April 2022
View article titled, Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer
Open the PDF for Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer in another window
Journal Articles

Abstract PR06: Tumor-infiltrating B cells colocalize with CD4 T effector cells within tertiary lymphoid structures to present antigen and educate the antitumor immune response in human primary tumors

Ayana T. Ruffin, Anthony R. Cillo, Sheryl Kunning, Robert L. Ferris, Dario A.A. Vignali, Tullia C. Bruno
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12_Supplement_2): PR06.
https://doi.org/10.1158/1557-3265.AACRAHNS19-PR06
Published: 15 June 2020
View article titled, Abstract PR06: Tumor-infiltrating B cells colocalize with CD4 T effector cells within tertiary lymphoid structures to present antigen and educate the antitumor immune response in human primary tumors
Journal Articles

Abstract IA17: Cellular interactions and regulatory mechanisms in head and neck cancer

Dario A.A. Vignali
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12_Supplement_2): IA17.
https://doi.org/10.1158/1557-3265.AACRAHNS19-IA17
Published: 15 June 2020
View article titled, Abstract IA17: Cellular interactions and regulatory mechanisms in head and neck cancer
Journal Articles

Abstract TMIM-063: TARGETING NEUROPILIN-1+ T REGULATORY CELLS IN PATIENTS WITH HIGH GRADE SEROUS OVARIAN CANCER DECREASES TREG-SPECIFIC SUPPRESSION OF CD8+ T CELLS

Anthony R. Cillo, Christopher A. Chuckran, Mengting Liao, Francesmary Modugno, Robert Edwards, Lan Coffman, Dario A.A. Vignali, Tullia C. Bruno
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): TMIM-063.
https://doi.org/10.1158/1557-3265.OVCASYMP18-TMIM-063
Published: 15 November 2019
View article titled, Abstract TMIM-063: TARGETING NEUROPILIN-1+ T REGULATORY CELLS IN PATIENTS WITH HIGH GRADE SEROUS OVARIAN CANCER DECREASES TREG-SPECIFIC SUPPRESSION OF CD8+ T CELLS